Karpas Strategies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-959
Closed -$236K 118
2023
Q3
$236K Sell
959
-690
-42% -$189K 0.09% 106
2023
Q2
$501K Buy
1,649
+3
+0.2% +$834 0.17% 81
2023
Q1
$434K Sell
1,646
-278
-14% -$70.6K 0.15% 85
2022
Q4
$462K Buy
1,924
+10
+0.5% +$2.24K 0.16% 83
2022
Q3
$352K Buy
1,914
+6
+0.3% +$1.2K 0.13% 88
2022
Q2
$321K Buy
1,908
+4
+0.2% +$859 0.11% 94
2022
Q1
$477K Hold
1,904
0.15% 88
2021
Q4
$489K Buy
1,904
+4
+0.2% +$979 0.16% 82
2021
Q3
$472K Hold
1,900
0.16% 80
2021
Q2
$393K Hold
1,900
0.14% 88
2021
Q1
$358K Buy
+1,900
New +$335K 0.14% 88

Other funds holding HCA

Karpas Strategies's HCA Position: Q4 2023 in Review

Karpas Strategies sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 959 shares — an estimated $236K sold.

Karpas Strategies first reported a position in HCA in Q1 2021 and held it in 11 quarters. The position peaked at $501K in Q2 2023. 1,057 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Karpas Strategies reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Karpas Strategies sold 959 HCA Healthcare shares in Q4 2023, an estimated $236K.
  • Karpas Strategies first reported a position in HCA Healthcare in Q1 2021 and held it in 11 quarters.
  • Karpas Strategies's HCA Healthcare position peaked at $501K in Q2 2023.
  • 1,057 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Karpas Strategies's 13F filing for Q4 2023, filed 7 Feb 2024.